US › Healthcare

Myomo Inc (MYO)

US · Healthcare · Medical Devices

$1.08+3.85%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$10.1M

Revenue YoY

+2.9%

Net profit

$-3.0M

Profit YoY

+13.2%

EPS

$-0.09

EPS estimate

$-0.11

Net margin

-29.8%

EPS came in at -0.09 against a street estimate of -0.11 — a beat of 18.2%.

Key statistics

Market cap

$39.0M

Forward P/E

0.0

P/B

4.34

Book value

$0.23

EPS (TTM)

$-0.36

52-week high

$2.02

52-week low

$0.60

50-day MA

$1.12

200-day MA

$0.93

Beta

1.44

Analyst view

Analysts rate Myomo Inc a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $4.42.

Shareholding

Insiders

9.10%

Institutions

40.45%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Myomo Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.